CDH Investments-backed Chinese Biotechnology Firm Mabpharm Files For Hong Kong IPO
August 24, 2018 — 11:15 CST
This Data Is Locked!
This area is available only to Subscribers.
Mabpharm Limited, a Taizhou, Jiangsu Province-based biotechnology company, has filed for an initial public offering in Hong Kong, becoming the latest Chinese biotech firm rushing... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals